CLINICAL_TRIALS
withdrawal
· 2022-10-10
Clinical Trial Update: Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency [Phase 4]
Summary
A Phase 4 clinical trial evaluating quercetin for cardio-skeletal muscle health in estrogen deficiency has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Menopause Related Conditions | Phase 4 | Status: WITHDRAWN